NIH-funded program shows CNM-Au8® benefits in ALS. Clene Nanomedicine's data reveals improved survival with treatment. AM ALS optimistic.

Unusual Whales
2025.12.04 15:05
New data from Clene Nanomedicine has shown promising results for the treatment CNM-Au8® in ALS patients. Released on December 4, 2025, the analysis revealed a notable increase in survival rates. I AM ALS expressed enthusiasm for these findings, which indicate the potential for continued progress in combating the disease. The study marks a significant step forward in the fight against ALS, with the treatment showing promise in improving outcomes for patients.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer